Vol. 20, Issue 1
Dr. Claudia Lucchinetti of the Mayo Clinic in Minnesota was the featured speaker at the Research General Session of the Society’s annual national meeting. She spoke about her current work on “The MS Lesion Project” to an audience that included not only the 950-plus volunteers and staff who went to New Orleans in November, but the many others who have since visited the Society’s Web site where her presentation is archived (http://www.meetingcast.com/nmss2001). A question-and-answer session with Dr. Lucchinetti, Dr. Austin Sumner of Louisiana State University’s Medical School, and Dr. Stephen Reingold, the Society’s VP for research, was Web-cast live at the conference.
“The MS Lesion Project” seeks to correlate data from patient histories and tests to studies of tissue samples from actual areas of MS damage in patients’ central nervous systems. The questions are huge: Is MS more than one disease? Why do some people respond dramatically to certain therapies, while others gain little?
The international team, led by Dr. Lucchinetti, has now identified nearly 500 people with MS who for one reason or another have undergone a brain biopsy. They represent a precious resource for this study. Dr. Lucchinetti and her colleagues hope this project will give physicians a tool for determining in advance who will benefit from specific therapies.
To see the presentation, visit 2001 National Leadership Conference Webcast Series (http://www.meetingcast.com/nmss2001). If you don’t have access to the Internet at home, your local library may offer it. Call your chapter at 1-800-FIGHT-MS (1-800-344-4867) for information.
For additional information
© 2002 The National Multiple Sclerosis Society